HI HB 449
died on adjournmentRELATING TO ECONOMIC DEVELOPMENT.
Hawaii · 2026 Regular Session · lower
Quick answers
Did HI HB 449 pass?
No. HI HB 449 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-12-08): Carried over to 2026 Regular Session.
What is HI HB 449 about?
Requires the Hawaii Technology Development Corporation to prioritize funding for certain Hawaii-based businesses. Appropriates funds to assist in the development and promotion of Hawaii-manufactured products through the INNOVATE Hawaii program. Requires reports to the Legislature. Effective 7/1/3000. (SD1)
Who sponsors HI HB 449?
ILAGAN is the primary sponsor of HI HB 449.
Description
Requires the Hawaii Technology Development Corporation to prioritize funding for certain Hawaii-based businesses. Appropriates funds to assist in the development and promotion of Hawaii-manufactured products through the INNOVATE Hawaii program. Requires reports to the Legislature. Effective 7/1/3000. (SD1)
- Introduced
- 2025-01-21
- Latest action
- 2025-12-08 — Carried over to 2026 Regular Session.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- ILAGANprimary
Committees
Not provided by source.
Action timeline
2025-12-08
Carried over to 2026 Regular Session.
carried-over
2025-03-21
Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.
passage,reading-2,referral-committee
2025-03-21
Reported from EDT (Stand. Com. Rep. No. 1326) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.
2025-03-20
The committee(s) on EDT recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in EDT were as follows: 5 Aye(s): Senator(s) DeCoite, Wakai, Fukunaga, Kim, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
committee-passage-favorable
2025-03-17
The committee(s) on EDT has scheduled a public hearing on 03-20-25 1:00PM; Conference Room 229 & Videoconference.
2025-03-06
Referred to EDT, WAM.
referral-committee
2025-03-06
Passed First Reading.
reading-1
2025-03-06
Received from House (Hse. Com. No. 239).
introduction,receipt
2025-03-04
Passed Third Reading with none voting aye with reservations; none voting no (0) and Representative(s) Pierick, Ward excused (2). Transmitted to Senate.
passage
2025-02-28
Reported from FIN (Stand. Com. Rep. No. 1116), recommending passage on Third Reading.
2025-02-26
The committee on FIN recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 15 Ayes: Representative(s) Yamashita, Takenouchi, Grandinetti, Holt, Hussey, Keohokapu-Lee Loy, Kitagawa, Kusch, Lamosao, Lee, M., Miyake, Morikawa, Templo, Alcos, Reyes Oda; Ayes with reservations: none; Noes: none; and 1 Excused: Representative(s) Ward.
committee-passage-favorable
2025-02-26
Bill scheduled for decision making on Wednesday, 02-26-25 11:00AM in conference room 308 VIA VIDEOCONFERENCE.
2025-02-25
The committee(s) on FIN recommend(s) that the measure be deferred until 02-26-25.
deferral
2025-02-21
Bill scheduled to be heard by FIN on Tuesday, 02-25-25 2:00PM in House conference room 308 VIA VIDEOCONFERENCE.
2025-02-05
Passed Second Reading as amended in HD 1 and referred to the committee(s) on FIN with none voting aye with reservations; none voting no (0) and Representative(s) Cochran, Ward excused (2).
reading-2,referral-committee
2025-02-05
Reported from TOU/ECD (Stand. Com. Rep. No. 157) as amended in HD 1, recommending passage on Second Reading and referral to FIN.
2025-01-30
The committee on ECD recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 7 Ayes: Representative(s) Ilagan, Hussey, Holt, Tam, Templo, Todd, Matsumoto; Ayes with reservations: none; 0 Noes: none; and 0 Excused: none.
committee-passage-favorable
2025-01-30
The committee on TOU recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 7 Ayes: Representative(s) Tam, Templo, Holt, Hussey, Ilagan, Todd, Matsumoto; Ayes with reservations: none; 0 Noes: none; and 0 Excused: none.
committee-passage-favorable
2025-01-27
Bill scheduled to be heard by TOU/ECD on Thursday, 01-30-25 9:00AM in House conference room 423 VIA VIDEOCONFERENCE.
2025-01-27
Re-referred to TOU/ECD, FIN, referral sheet 4
referral-committee
2025-01-21
Referred to TOU, ECD, FIN, referral sheet 2
referral-committee
2025-01-21
Introduced and Pass First Reading.
introduction,reading-1
2025-01-17
Pending introduction.
Versions
Documents
Votes
The committee on TOU recommend that the measure be PASSED, WITH AMENDMENTS.
2025-01-30 · pass · 7-0
Member-level votes (7)
- Tam: yes
- Templo: yes
- Holt: yes
- Hussey: yes
- Ilagan: yes
- Todd: yes
- Matsumoto: yes
The committee on ECD recommend that the measure be PASSED, WITH AMENDMENTS.
2025-01-30 · pass · 7-0
Member-level votes (7)
- Ilagan: yes
- Hussey: yes
- Holt: yes
- Tam: yes
- Templo: yes
- Todd: yes
- Matsumoto: yes
The committee on FIN recommend that the measure be PASSED, UNAMENDED.
2025-02-26 · pass · 15-0
Member-level votes (17)
- Yamashita: yes
- Takenouchi: yes
- Grandinetti: yes
- Holt: yes
- Hussey: yes
- Keohokapu-Lee Loy: yes
- Kitagawa: yes
- Kusch: yes
- Lamosao: yes
- Lee: yes
- M: yes
- Miyake: yes
- Morikawa: yes
- Templo: yes
- Alcos: yes
- Reyes Oda: yes
- Ward: not voting
The committee(s) on EDT recommend(s) that the measure be PASSED, WITH AMENDMENTS.
2025-03-20 · pass · 5-0
Member-level votes (5)
- Kim: yes
- Awa: yes
- DeCoite: yes
- Wakai: yes
- Fukunaga: yes
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:20:09.051962Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=HI&identifier=HB 449. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.